Loading...
•
Mar 31, 2023
Puma Biotechnology Q1 2023 Earnings Report
Puma Biotechnology reported positive net income and increased total revenue compared to the same quarter last year.
Key Takeaways
Puma Biotechnology reported a net income of $1.4 million for Q1 2023, a significant improvement from the net loss of $3.4 million in Q1 2022. Total revenue increased to $52.8 million, driven by growth in both net product revenue and royalty revenue.
Puma Biotechnology reported net income of $1.4 million, or $0.03 per basic and diluted share.
Non-GAAP adjusted net income was $4.2 million, or $0.09 per basic and diluted share.
Total revenue increased to $52.8 million, with product revenue of $46.8 million and royalty revenue of $6.0 million.
The company had cash, cash equivalents and marketable securities of $71.2 million as of March 31, 2023.
Revenue by Segment
Forward Guidance
Puma Biotechnology anticipates net product revenue between $47 million and $50 million and royalty revenue between $2 million and $3 million for the second quarter of 2023. The company expects net income to be between $0 million and $1.5 million for the second quarter of 2023. For the full year 2023, the company anticipates net product revenue between $205 million and $210 million and royalty revenue between $25 million and $30 million. The company expects net income to be between $20 million and $24 million for the full year 2023.
Positive Outlook
- Net Product Revenue $47 - $50 million (Q2 2023)
- Royalty Revenue $2 - $3 million (Q2 2023)
- Net Income/(Loss) $0 - $1.5 million (Q2 2023)
- Net Product Revenue $205 - $210 million (Full Year 2023)
- Royalty Revenue $25 - $30 million (Full Year 2023)
Challenges Ahead
- Net Income/(Loss) $20 - $24 million (Full Year 2023)
- Gross to Net Adjustment 20% - 21% (Q2 2023)
- Gross to Net Adjustment 19% - 20% (Full Year 2023)
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...